Companies: 10,795·Total market cap: $144.5T
International Stem Cell Corporation

International Stem Cell Corporation

ISCOOTCHealthcare● Active
$0.17
+$0.00(+0.00%)
Market Cap$1360746
P/E Ratio—
52W High$0.27
52W Low$0.11
SEC Filings

International Stem Cell Corporation (ISCO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001355790 · ISCO · OTC · as of Jun 10, 2026

Filing snapshot

814
Total Filings
10-Q
Latest Form
2026-05-14
Most Recent
2007
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001355790 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-30
Fiscal Year End
Mar 30, 2026
Accession No.
0001193125-26-131723
Primary Document
isco-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001355790 · Accession 0001193125-26-131723

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-14
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2025-11-18Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-14
View
ARSARS
ARS
2026-04-29
View
DEF 14AProxy Statement
DEF 14A
2026-04-29
View
10-KAnnual Report
10-K
2026-03-30
View
8-KCurrent Report
CURRENT REPORT
2025-11-18
View
10-QQuarterly Report
10-Q
2025-11-13
View
8-KCurrent Report
CURRENT REPORT
2025-09-16
View
10-QQuarterly Report
10-Q
2025-08-14
View
10-QQuarterly Report
10-Q
2025-05-14
View
ARSARS
ARS
2025-04-24
View
DEF 14AProxy Statement
DEF 14A
2025-04-24
View
10-KAnnual Report
10-K
2025-03-28
View
10-QQuarterly Report
10-Q
2024-11-13
View
8-KCurrent Report
CURRENT REPORT
2024-09-17
View
10-QQuarterly Report
10-Q
2024-08-13
View
Showing 1–15 of 484 filingsForm 4 / 144 hidden· 814 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001355790  |  Exchange: OTC · Healthcare

International Stem Cell Corporation (OTC: ISCO) has submitted 814 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2007. As a Healthcare sector company with CIK 0001355790, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is International Stem Cell Corporation's most comprehensive regulatory disclosure. The most recent International Stem Cell Corporation 10-K was filed on 2026-03-30 for fiscal year ending 2026. Historical ISCO 10-K annual reports are available from 2006 through 2026.

Investors researching International Stem Cell Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
BMNDF SEC Filings →VCNX SEC Filings →NSTM SEC Filings →BICTF SEC Filings →CAIHF SEC Filings →BIOR SEC Filings →EVFM SEC Filings →UNBX SEC Filings →
→ ISCO Financials→ ISCO Earnings→ ISCO Insider Trades

Frequently Asked Questions

ISCO SEC Filings · 8 questions

International Stem Cell Corporation (ISCO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 814 filings and access original documents at no cost. International Stem Cell Corporation's CIK is 0001355790.

ISCO SEC filingsInternational Stem Cell Corporation SEC documentsfind ISCO 10-K